Adamis pharmaceuticals provides update on first quarter 2021 financial results conference call

San diego, may 17, 2021 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp) today announced that it is postponing its previously announced investor conference call scheduled to be held on monday, may 17, 2021, at 2 p.m. pacific time. the company filed a form 12b-25 with the securities and exchange commission today in order to extend the due date of its quarterly report on form 10-q for the three months ended march 31, 2021, by five calendar days as permitted by rule 12b-25 under the securities exchange act of 1934, and is postponing the investor call in light of that filing delay. the company will announce a new date and time for a rescheduled investor call.
ADMP Ratings Summary
ADMP Quant Ranking